Exactly. They will approve a new high dollar UNPROVEN drug and ignore cheap alternatives. Tell me the “pandemic” isn’t being pushed by big pharma.
the ANTICOV study in Africa is all about low cost proven drugs. It’s being run in 18 african nations. They’re trialing Nitazoxanide which is pretty cheap. Ivermectin is being widely phased out because of drug resistance.
https://journals.asm.org/doi/10.1128/AAC.00713-16
https://pubmed.ncbi.nlm.nih.gov/27246778/
molnupiravir was in development before 2020, as EID-2801. It works by injecting errors into the viral dna via “nucleoside analogs’, like remdisivir works but may overcome virus that is already remdisiver-resistant
April 2020
https://pubmed.ncbi.nlm.nih.gov/32253226/
and in formal trials back in Jan 2021
https://pubmed.ncbi.nlm.nih.gov/33273742/
and talked up in Mar 2021
https://pubmed.ncbi.nlm.nih.gov/33561864/